RGDS peptide

RGDS peptide

Catalog Number:
L002372399APE
Mfr. No.:
APE-B7412
Price:
$210
  • Size:
    10mg
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          RGDS peptide contains the RGD motif which is an antagonist of integrin [1, 2].
          Integrins are cell-surface receptors that recognize RGD motifs present in various extracellular matrix proteins such as fibronectin, vitronectin, laminin, fibrinogen, von Willebrand factor, osteopontin, thrombospondin, and collagen as well as in disintegrins. Integrins activation triggers different signals regulating cell adhesion, migration, survival, apoptosis as well as processes such as angiogenesis, thrombosis and osteoporosis [1].
          In SK-MEL-110 cells, RGDS at 500 μg/ml significantly inhibited melanoma cells proliferation induced by human fibroblast growth factor-2 (FGF-2). Furthermore, RGDS treatment (48 h, 500 μg/ml) increased the percentage of cells in sub-G1-phase from 3% (with FGF-2 alone) to 13.2% (with FGF-2 and RGDS), indicating that RGDS might induce apoptosis in melanoma cells, in the presence of FGF-2 [1].
          In a guinea pig model of allergic asthma, topical treatment of the airways with intranasally instilled RGDS (2.5 mM, 200 μl) attenuated allergen-induced airway smooth muscle hyperplasia and hypercontractility as well as increased pulmonary expression of smooth muscle myosin heavy chain and the proliferative marker proliferating cell nuclear antigen [2].

          [1]. Aguzzi M S, Fortugno P, Giampietri C, et al. Intracellular targets of RGDS peptide in melanoma cells. Molecular Cancer, 2010, 9(84): 1-10.
          [2]. Dekkers B G, Bos I S, Gosens R, et al. The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. American Journal of Respiratory and Critical Care Medicine, 2010, 181(6): 556-565.

      • Properties
        • Alternative Name
          (6R,12S,15R)-1,1,6-triamino-12-(carboxymethyl)-15-(hydroxymethyl)-7,10,13-trioxo-2,8,11,14-tetraazahexadec-1-en-16-oic acid
          CAS Number
          91037-65-9
          Molecular Formula
          C15H27N7O8
          Molecular Weight
          433.42
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          ≥21.65 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO
          Storage
          Desiccate at -20°C

          * For Research Use Only

    We Also Recommend

    BMS 493

    $300

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.